Molecular docking: a powerful approach for structure-based drug discovery.
By Xuanyu Meng, Hong-Xing Zhang, Mihaly Mezei, Meng Cui. 2011
3,197 citations recorded by the source corpus.
Molecular docking has become an increasingly important tool for drug discovery. In this review, we present a brief introduction of the available molecular docking methods, and their development and applications in drug discovery. The relevant basic theories, including sampling algorithms and scoring functions, are summarized. The differences in and performance of available docking software are also discussed. Flexible receptor molecular docking approaches, especially those including backbone flexibility in receptors, are a challenge for available docking methods. A recently developed Local Move Monte Carlo (LMMC) based approach is introduced as a potential solution to flexible receptor docking problems. Three application examples of molecular docking approaches for drug discovery are provided.
Subfields: Computational Theory and Mathematics, Environmental Chemistry, Materials Chemistry, Evaluation & Benchmarks
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Luca Pinzi
- Giulio Rastelli
- Tommi S. Jaakkola
- Glaucius Oliva
- L. Ferreira
- Ricardo N Dos Santos
- Hannes Stärk
- Maria Batool
In Environmental Chemistry
In Materials Chemistry
- Glaucius Oliva
- Hannes Stärk
- Adriano Defini Andricopulo
- Giulio Rastelli
- L. Ferreira
- Tommi S. Jaakkola
- Ricardo N Dos Santos
- Luca Pinzi
In Evaluation & Benchmarks
- Glaucius Oliva
- Hannes Stärk
- Adriano Defini Andricopulo
- Giulio Rastelli
- L. Ferreira
- Tommi S. Jaakkola
- Ricardo N Dos Santos
- Luca Pinzi
Citations in the corpus
- Molecular Docking and Structure-Based Drug Design Strategies (2015, methodology): “Molecular docking is one of the most frequently used methods in SBDD because of its ability to predict, with a substantial degree of accuracy, the conformation of small-molecule ligands within the appropriate target binding site (Figure 2) [21].”
- Benchmarking AlphaFold‐enabled molecular docking predictions for antibiotic discovery (2022, methodology): “Model predictions based on the following rescoring functions were ensembled in sequence: RF-Score, NNScore, PLEC score, and RF-Score-VS.”
- Structure-Based Virtual Screening: From Classical to Artificial Intelligence (2020, background): “Among the techniques of SBVS, molecular docking is noteworthy due to its low computational cost and good results achieved (Meng et al., 2011).”
- A Structure-Based Drug Discovery Paradigm (2019, methodology): “Molecular docking predicts the conformation and binding of ligands within a target active site with high accuracy; therefore, it is the most popular technique in SBDD [47,48].”
- Structure-aware Interactive Graph Neural Networks for the Prediction of Protein-Ligand Binding Affinity (2021, background): “With the development of structural biology and protein structure prediction, especially the recent Alphafold II model [4], there are growing three-dimensional (3D) structure protein data, which enables a new paradigm for structure-based drug discovery [3, 13, 27].”
- Molecular Docking: Shifting Paradigms in Drug Discovery (2019, background): “The possibilities offered by molecular docking in drug discovery are well established [3,5,7,18,47,49,50,63].”
- Molecular dynamics simulations and novel drug discovery (2018, methodology): “Structure-based virtual screening based on molecular docking methods has become an indispensable tool in drug discovery [13,15,103].”